Terms: = Pancreatic cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
9 results:
1. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of super-resolution on 50 pancreatic cancer patients with real-time cine MRI from 0.35T MRgRT.
Chun J; Lewis B; Ji Z; Shin JI; Park JC; Kim JS; Kim T
Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34375963
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and characterization of NCC-PLPS1-C1, a novel patient-derived cell line of pleomorphic liposarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Mar; 34(2):688-697. PubMed ID: 33205363
[TBL] [Abstract] [Full Text] [Related]
4. YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling.
Zhou Q; Bauden M; Andersson R; Hu D; Marko-Varga G; Xu J; Sasor A; Dai H; Pawłowski K; Said Hilmersson K; Chen X; Ansari D
J Transl Med; 2020 Feb; 18(1):77. PubMed ID: 32054505
[TBL] [Abstract] [Full Text] [Related]
5. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
6. Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience.
Khan K; Rane JK; Cunningham D; Rao S; Watkins D; Starling N; Kalaitzaki E; Forster M; Braconi C; Valeri N; Gerlinger M; Chau I
Clin Colorectal Cancer; 2019 Mar; 18(1):64-71.e1. PubMed ID: 30404764
[TBL] [Abstract] [Full Text] [Related]
7. Percutaneous liver biopsy: retrospective study of primary and secondary hepatic lymphoma in twenty-one patients.
Bai YF; Liu JM; Zhang XM; Jiang CZ; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):58-64. PubMed ID: 28119260
[TBL] [Abstract] [Full Text] [Related]
8. Automatic tracking of arbitrarily shaped implanted markers in kilovoltage projection images: a feasibility study.
Regmi R; Lovelock DM; Hunt M; Zhang P; Pham H; Xiong J; Yorke ED; Goodman KA; Rimner A; Mostafavi H; Mageras GS
Med Phys; 2014 Jul; 41(7):071906. PubMed ID: 24989384
[TBL] [Abstract] [Full Text] [Related]
9. Rash to the mTOR inhibitor everolimus: systematic review and meta-analysis.
Ramirez-Fort MK; Case EC; Rosen AC; Cerci FB; Wu S; Lacouture ME
Am J Clin Oncol; 2014 Jun; 37(3):266-71. PubMed ID: 23241507
[TBL] [Abstract] [Full Text] [Related]
